265 related articles for article (PubMed ID: 30742665)
21. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
24. Clinico-histomorphologic Characteristics of Lupus Nephritis, Experience at a Center at Dhaka.
Islam SMJ; Rahman AKMM; Yasmin S; Giti S
Saudi J Kidney Dis Transpl; 2021; 32(6):1754-1763. PubMed ID: 35946290
[TBL] [Abstract][Full Text] [Related]
25. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
26. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis.
Moroni G; Vercelloni PG; Quaglini S; Gatto M; Gianfreda D; Sacchi L; Raffiotta F; Zen M; Costantini G; Urban ML; Pieruzzi F; Messa P; Vaglio A; Sinico RA; Doria A
Ann Rheum Dis; 2018 Sep; 77(9):1318-1325. PubMed ID: 29730634
[TBL] [Abstract][Full Text] [Related]
27. Protective role of anti-ribosomal P antibody in patients with lupus nephritis.
Kang JH; Park DJ; Choi SE; Yim YR; Kim JE; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee JK; Lee SS
Int J Rheum Dis; 2019 May; 22(5):913-920. PubMed ID: 30809965
[TBL] [Abstract][Full Text] [Related]
28. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
[TBL] [Abstract][Full Text] [Related]
29. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
[TBL] [Abstract][Full Text] [Related]
30. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
[TBL] [Abstract][Full Text] [Related]
32. IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.
Zickert A; Amoudruz P; Sundström Y; Rönnelid J; Malmström V; Gunnarsson I
BMC Immunol; 2015 Feb; 16(1):7. PubMed ID: 25887118
[TBL] [Abstract][Full Text] [Related]
33. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
[TBL] [Abstract][Full Text] [Related]
34. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
[TBL] [Abstract][Full Text] [Related]
35. The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study.
Nakagawa S; Toyama T; Iwata Y; Oshima M; Ogura H; Sato K; Yamamura Y; Miyakawa T; Kitajima S; Hara A; Sakai N; Shimizu M; Wada T
Lupus; 2021 Oct; 30(11):1739-1746. PubMed ID: 34284677
[TBL] [Abstract][Full Text] [Related]
36. Soluble AXL as a marker of disease progression and survival in melanoma.
Flem-Karlsen K; Nyakas M; Farstad IN; McFadden E; Wernhoff P; Jacobsen KD; Flørenes VA; Mælandsmo GM
PLoS One; 2020; 15(1):e0227187. PubMed ID: 31917795
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of serial kidney biopsies in lupus nephritis.
Alsuwaida AO
Mod Rheumatol; 2014 May; 24(3):453-6. PubMed ID: 24251991
[TBL] [Abstract][Full Text] [Related]
38. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
39. High-Sensitivity Troponin T and Soluble Form of AXL as Long-Term Prognostic Biomarkers after Heart Transplantation.
Mirabet S; García-Osuna A; Garcia de Frutos P; Ferrero-Gregori A; Brossa V; Lopez L; Leta R; Garcia-Picart J; Padro JM; Sánchez-Quesada JL; Cinca J; Ordonez-Llanos J; Roig E
Dis Markers; 2018; 2018():6243529. PubMed ID: 30245754
[TBL] [Abstract][Full Text] [Related]
40. Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.
Bellan M; Quaglia M; Nerviani A; Mauro D; Lewis M; Goegan F; Gibbin A; Pagani S; Salmi L; Molinari L; Castello LM; Avanzi GC; Cantaluppi V; Pirisi M; Sainaghi PP; Pitzalis C
Clin Exp Rheumatol; 2021; 39(1):132-138. PubMed ID: 32573415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
